Health
Malaria vaccine shows 87% efficacy in clinical trial
Medical Xpress·November 20, 2026

The novel, genetically attenuated whole-parasite PfSPZ-LARC2 Vaccine for malaria achieved an 87% efficacy rate in preventing infection during a recent phase 1 trial.
Read the full story at Medical Xpress →